WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New ATCvet codes 2016

 Updates included in the ATCvet Index valid from 2016.

ATC codeATCvet level name
QA02BD11pantoprazole, amoxicillin, clarithromycin and metronidazole
QA05AA04obeticholic acid
QA07AA94enramycin
QA08AA62bupropion and naltrexone
QA10AE56insulin degludec and liraglutide
QA10BD20metformin and empagliflozin
QA10BD21saxagliptin and dapagliflozin
QA10BX14dulaglutide
QA16AB13asfotase alfa
QA16AB14sebelipase alfa
QA16AX11sodium benzoate
QB01AC27selexipag
QC01CA27droxidopa
QC09BX02perindopril and bisoprolol
QC09DB08valsartan and lercanidipine
QC09DX04valsartan and sacubitril
QC10BX10rosuvastatin and valsartan
QC10BX11atorvastatin, amlodipine and perindopril
QD01AC18luliconazole
QD01AC19efinaconazole
QD11AH91 lokivetmab
QG02CX02flibanserin
QG03AC10drospirenone
QG03CC07conjugated estrogens and bazedoxifene
QH01CA97 triptorelin
QI09AL08porcine circovirus + mycoplasma
QI10AL05 infectious pancreatic necrosis (IPN) virus + pancreatic disease (SPD) virus + aeromonas + moritella + vibrio
QJ01DD52ceftazidime, combinations
QJ01DI54ceftolozane and enzyme inhibitor
QJ01MB08nemonoxacin
QJ01XX11tedizolid
QJ02AC05isavuconazole
QJ05AR15 atazanavir and cobicistat
QJ05AR16lamivudine and raltegravir
QJ05AR17emtricitabine and tenofovir alafenamide
QJ05AR18emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
QJ05AR19emtricitabine, tenofovir alafenamide and rilpivirine
QJ05AX16dasabuvir
QJ05AX65sofosbuvir and ledipasvir
QJ05AX66dasabuvir, ombitasvir, paritaprevir and ritonavir
QJ05AX67ombitasvir, paritaprevir and ritonavir
QL01XC17nivolumab
QL01XC18pembrolizumab
QL01XC19blinatumomab
QL01XC21ramucirumab
QL01XC22necitumumab
QL01XE29lenvatinib
QL01XE31nintedanib
QL01XE32cediranib
QL01XE33palbociclib
QL01XE34tivozanib
QL01XX48sonidegib
QL01XX49belinostat
QL01XX50ixazomib
QL04AA35begelomab
QL04AC12brodalumab
QM04AB05lesinurad
QM05BB08zoledronic acid, calcium and colecalciferol, sequential
QM09AX03ataluren
QM09AX04drisapersen
QN03AX23brivaracetam
QN03AX91 potassium bromide
QN05AX16brexpiprazole
QN05CH03tasimelteon
QN06BA13armodafinil
QN07XX11pitolisant
QP53AG30combinations
QP53BE Isoxazolines
QP53BE03sarolaner
QP53BE04lotilaner
QP54AA55selamectin, combinations
QR02AA21 octenidine
QR02AX02ibuprofen
QR03AK12salmeterol and budesonide
QR03AL06olodaterol and tiotropium bromide
QR03DX08reslizumab
QR07AX30ivacaftor and lumacaftor
QS01XA23sirolimus
QV03AB37idarucizumab

Last updated: 2016-01-15